There isn't an Allogeneic CAR T on market right now that's why Allogene is seen as "first and best in class" as well. BP are investing in alternate cancer treatment and there are more than Pfizer, Allogene's solid cancer IP isn't as advanced as IMU and this has always been the massive cancer market especially with OnCARlytics.
IMU Price at posting:
4.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)